Chemoinformaics analysis of N,N,-Dimethylhuperzine A
| Molecular Weight | 270.376 | nRot | 1 |
| Heavy Atom Molecular Weight | 248.2 | nRig | 17 |
| Exact Molecular Weight | 270.173 | nRing | 3 |
| Solubility: LogS | -2.569 | nHRing | 1 |
| Solubility: LogP | 2.304 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 42 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 2 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 46.0614 |
| nHD | 1 | BPOL | 25.2186 |
| QED | 0.796 |
| Synth | 5.026 |
| Natural Product Likeliness | 1.31 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.008 |
| Pgp-sub | 0.02 |
| HIA | 0.007 |
| CACO-2 | -4.675 |
| MDCK | 0.0000153 |
| BBB | 0.844 |
| PPB | 0.614736 |
| VDSS | 2.05 |
| FU | 0.507739 |
| CYP1A2-inh | 0.042 |
| CYP1A2-sub | 0.934 |
| CYP2c19-inh | 0.365 |
| CYP2c19-sub | 0.939 |
| CYP2c9-inh | 0.104 |
| CYP2c9-sub | 0.77 |
| CYP2d6-inh | 0.052 |
| CYP2d6-sub | 0.854 |
| CYP3a4-inh | 0.224 |
| CYP3a4-sub | 0.921 |
| CL | 9.039 |
| T12 | 0.223 |
| hERG | 0.005 |
| Ames | 0.072 |
| ROA | 0.208 |
| SkinSen | 0.035 |
| Carcinogencity | 0.947 |
| EI | 0.01 |
| Respiratory | 0.968 |
| NR-Aromatase | 0.014 |
| Antiviral | No |
| Prediction | 0.595932 |